Actively Recruiting
PRE-EMPT Study Screening and Two-Year Treatment Trial of Rosuvastatin and Colchicine for Early Heart Artery Plaque
Led by Duke University · Updated on 2026-10-07
1500
Participants Needed
23
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Heart disease is a leading cause of death across diverse groups in the United States. Researchers are evaluating whether screening for early heart artery plaque and early treatment can help manage mild heart disease. This study focuses on adults with low 10-year heart disease risk but who have risk factors and early signs of plaque buildup in their heart arteries. The trial has two phases screening and treatment. Screening uses special CT scans to detect calcium or plaque in heart arteries. In the treatment phase, about 1,500 participants with specific plaque findings are randomly assigned to take either rosuvastatin, colchicine, both medications, or placebos daily for two years. All participants receive guidance on heart-healthy lifestyle changes. Study drugs are mailed to participants homes, and visits include mostly virtual check-ins and a few in-person imaging appointments. Participants will attend up to two in-person screening visits and several phone visits during treatment, with imaging scans at the start and end of the trial. Blood samples are collected at home using mailed kits at multiple time points. Researchers will measure changes in plaque volume in heart arteries using advanced scans at two years, along with medication adherence and safety. The total study duration for participants is approximately two years.
CONDITIONS
Brief Title
PRE-EMPT: Prospective RandomizEd Evaluation and Management of Premature aTherosclerosis
Research Team
R
Rachel Olson, Project Manager
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here